Lineage Cell Therapeutics... (LCTX)
0.41
-0.01 (-1.63%)
At close: Apr 17, 2025, 3:59 PM
0.42
2.99%
After-hours: Apr 17, 2025, 07:52 PM EDT
13F Institute Ownership
Total Institutes of 123 in Lineage Cell Therapeutics expanded their positions with an increase of 9 investors compared to the previous quarter. An additional 12.51M shares, as total invested capital declined by $31.79M with ownership percentage increasing from 50.08% to 56.70%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Broadwood Capital Inc | 22.06% | 41.67M | +0.00% | 20.94M | 1.64% |
| Blackrock, Inc. | 5.35% | 10.09M | +1.76% | 5.07M | < 0.01% |
| Vanguard Group Inc | 4.57% | 8.63M | +0.37% | 4.34M | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.